Risk Factors Associated with a High Seroprevalence of Hepatitis C Virus Infection in Egyptian Blood Donors

Medhat A. DarwishDepartment of Microbiology, Ain Shams University Faculty of Medicine, Manchiet El Bakrey Hospital, Department of Pathology, University of Maryland School of Medicine, Epidemiology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Division of Geographic Medicine, Department of Medicine and the Center for Vaccine Development, University of Maryland School of Medicine, Cairo, Egypt

Search for other papers by Medhat A. Darwish in
Current site
Google Scholar
PubMed
Close
,
Tahani A. RaoufDepartment of Microbiology, Ain Shams University Faculty of Medicine, Manchiet El Bakrey Hospital, Department of Pathology, University of Maryland School of Medicine, Epidemiology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Division of Geographic Medicine, Department of Medicine and the Center for Vaccine Development, University of Maryland School of Medicine, Cairo, Egypt

Search for other papers by Tahani A. Raouf in
Current site
Google Scholar
PubMed
Close
,
Perween RushdyDepartment of Microbiology, Ain Shams University Faculty of Medicine, Manchiet El Bakrey Hospital, Department of Pathology, University of Maryland School of Medicine, Epidemiology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Division of Geographic Medicine, Department of Medicine and the Center for Vaccine Development, University of Maryland School of Medicine, Cairo, Egypt

Search for other papers by Perween Rushdy in
Current site
Google Scholar
PubMed
Close
,
Niel T. ConstantineDepartment of Microbiology, Ain Shams University Faculty of Medicine, Manchiet El Bakrey Hospital, Department of Pathology, University of Maryland School of Medicine, Epidemiology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Division of Geographic Medicine, Department of Medicine and the Center for Vaccine Development, University of Maryland School of Medicine, Cairo, Egypt

Search for other papers by Niel T. Constantine in
Current site
Google Scholar
PubMed
Close
,
Malla R. RaoDepartment of Microbiology, Ain Shams University Faculty of Medicine, Manchiet El Bakrey Hospital, Department of Pathology, University of Maryland School of Medicine, Epidemiology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Division of Geographic Medicine, Department of Medicine and the Center for Vaccine Development, University of Maryland School of Medicine, Cairo, Egypt

Search for other papers by Malla R. Rao in
Current site
Google Scholar
PubMed
Close
, and
Rober EdelmanDepartment of Microbiology, Ain Shams University Faculty of Medicine, Manchiet El Bakrey Hospital, Department of Pathology, University of Maryland School of Medicine, Epidemiology Branch, National Institute of Child Health and Human Development, National Institutes of Health, Division of Geographic Medicine, Department of Medicine and the Center for Vaccine Development, University of Maryland School of Medicine, Cairo, Egypt

Search for other papers by Rober Edelman in
Current site
Google Scholar
PubMed
Close
Restricted access

We performed serologic tests for hepatitis C virus (HCV) infection on sera obtained from 163 volunteer blood donors seen at one Cairo hospital. We found HCV infection in 36 donors (22%) measured by a second generation enzyme immunoassay. Thirty-five of these 36 positive sera were tested with a second generation recombinant immunoblot assay (RIBA-2); 22 (63%) were reactive and another 12 (34%) showed an indeterminate reaction. Overall, 13.6% (95% confidence interval [CI] = 8.3–18.9%) of these Egyptian blood donors were serologically confirmed to be infected with HCV. Of several demographic variables and medical risk factors examined, the serologically confirmed (RIBA-2 reactive) donors were significantly older than nonreactive donors, and the age-adjusted risk of being HCV-positive was significantly greater in individuals residing outside Cairo. A knowledge of having received injections, of having a history of schistosomiasis, or of having concomitant hepatitis B surface antigen or antibody were significantly associated with an increased risk of HCV-seropositivity; however, after adjusting for confounding demographic factors, only schistosomiasis (odds ratio = 8.9, 95% CI = 2.35–33.52) was significantly associated with HCV infection. The HCV seropositive rate of 13.6% among Egyptians is 5–35-fold higher than that reported from volunteer blood donors in other countries. Screening for HCV should be instituted in Egyptian blood banks. Blood banks that do not test for HCV should include a history of schistosomiasis in their exclusion criteria used for routine screening of blood donors.

Save